| Phase 3 |
| NCT06745908 |
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and… |
NSCLC Stage IV |
Recruiting |
| Phase 2/3 |
| NCT03022825 |
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG)… |
Bladder Cancer |
Active, Not Recruiting |
| Phase 2 |
| NCT07125872 |
Study of Relapsed/ Refractory B-cell Non- Hodgkin Lymphoma |
Relapsed B-Cell Non Hodgkin Lymphoma |
Recruiting |
| NCT07108036 |
A Study to Assess Anktiva in Patients With Long Covid-19. |
Long COVID |
Recruiting |
| NCT07123727 |
A Study to Examine Anktiva for the Treatment of COVID-19. |
Long COVID |
Recruiting |
| NCT06710288 |
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And… |
Platinum-resistant Ovarian Cancer |
Recruiting |
| NCT06829823 |
Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle… |
Non-muscle Invasive Bladder Cancer (NMIBC) |
Not Yet Recruiting |
| NCT04390399 |
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care… |
Pancreatic Cancer |
Active, Not Recruiting |
| NCT03228667 |
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously… |
Non-Small Cell Lung Cancer |
Active, Not Recruiting |
| NCT07477366 |
Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin… |
Relapsed B-Cell Non-Hodgkin Lymphoma |
Not Yet Recruiting |
| NCT07578558 |
NAI for Sepsis With Persistent Lymphopenia |
Sepsis |
Not Yet Recruiting |
| NCT07628062 |
Phase 2 Study of NAI, HPV Vaccine, and Nab-Paclitaxel in HPV-Positive Oropharyngeal… |
HPV-Positive Oropharyngeal Squamous Cell Carcinoma |
Not Yet Recruiting |
| NCT06061809 |
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma |
Glioblastoma |
Active, Not Recruiting |
| Phase 1/2 |
| NCT06800963 |
ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC… |
NMIBC |
Recruiting |
| NCT02138734 |
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle… |
Non-muscle Invasive Bladder Cancer |
Active, Not Recruiting |
| Phase 1 |
| NCT05618925 |
Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma |
Non Hodgkin's Lymphoma Refractory/Relapsed |
Recruiting |
| NCT07556757 |
A Safety and Efficacy Study of CD-19 t-haNK in Patients With B-cell Acute Lymphoblastic… |
B-ALL |
Recruiting |
| NCT05976828 |
IBRX-042 In Participants With HPV-Associated Tumors |
HPV-Related Carcinoma |
Active, Not Recruiting |
| NCT04898543 |
QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic… |
Metastatic Solid Tumor |
Active, Not Recruiting |
| NCT07488884 |
Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept… |
Pancreatic Cancer Resectable |
Not Yet Recruiting |
| NCT06334991 |
Study for Participants With Relapsed/Refractory Non-Hodgkin Lymphoma |
Non-Hodgkin Lymphoma Refractory/ Relapsed |
Active, Not Recruiting |
| Not specified |
| NCT05981131 |
Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer… |
Non Muscle Invasive Bladder Cancer |
Active, Not Recruiting |